8-K: Selectis Health Appoints Two New Directors
Director Appointment
Selectis Health, Inc. announced the appointment of Kent J. Lund and Lance Baller to its Board of Directors, effective January 1, 2026, bringing extensive legal, financial, and corporate governance expertise.
Summary
- Selectis Health, Inc. appointed Mr. Kent J. Lund and Mr. Lance Baller to its Board of Directors, effective January 1, 2026.
- Mr. Lund, age 70, is a seasoned business, legal, and securities professional with extensive public and private company board experience, including roles on the Colorado Securities Board and FINRA West Region Committee.
- Mr. Baller, age 51, is the co-founder and non-executive Chairman of Iofina Plc and has a strong background in corporate finance, capital markets, mergers and acquisitions, and governance, having previously served as CEO of Selectis Health from 2015 to 2023.
- Both appointees bring significant experience in corporate governance, financial oversight, and strategic business development.
Sentiment
Score: 8
Explanation: The appointments of two highly qualified and experienced individuals, particularly one with prior CEO experience at the company and another with deep legal and regulatory expertise, significantly strengthen the board's capabilities and governance structure. This is a strong positive for the company's strategic direction and oversight.
Positives
- Appointment of two highly experienced professionals to the Board of Directors.
- Mr. Lund brings deep legal, securities, and corporate governance expertise, including experience with regulatory bodies and audit committees.
- Mr. Baller offers extensive experience in corporate finance, capital markets, mergers and acquisitions, and has a proven track record of founding and growing businesses, including prior leadership roles at Selectis Health.
- The new directors enhance the board's capabilities in financial oversight, strategic planning, and compliance.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, focusing solely on board appointments.
Industry Context
The appointment of experienced directors like Mr. Lund and Mr. Baller is a standard practice for public companies seeking to strengthen their corporate governance and strategic oversight. Mr. Baller's background in iodine and halogen-based chemicals, as well as mining and aggregate, suggests a potential strategic alignment with resource-related industries, while Mr. Lund's legal and securities expertise is broadly beneficial for any public entity. These appointments reflect a common trend of boards seeking diverse skill sets to navigate complex regulatory and market environments.
Comparison to Industry Standards
- The appointment of directors with extensive legal, financial, and corporate governance backgrounds, such as Mr. Lund and Mr. Baller, aligns with best practices for public company boards, similar to those seen at established firms like Johnson & Johnson or Microsoft, which prioritize robust oversight.
- Mr. Lund's experience on regulatory bodies like the Colorado Securities Board and FINRA West Region Committee provides a level of compliance expertise comparable to that found in highly regulated sectors, such as banking (e.g., JPMorgan Chase board members) or pharmaceuticals (e.g., Pfizer board members).
- Mr. Baller's prior CEO and CFO roles at Iofina Plc, a publicly traded company, and his extensive M&A experience, are indicative of a profile often sought by boards looking for operational and transactional acumen, akin to executives joining boards of companies like Berkshire Hathaway or General Electric.
- His role as Audit Committee Chairman and Financial Expert under Sarbanes-Oxley for Cyber Hornet Trusts demonstrates a commitment to financial integrity and oversight that meets or exceeds the standards expected of audit committee members at major financial institutions.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | N/A | Kent J. Lund | 2026-01-01 | Appointment to the Board of Directors. |
| Director | N/A | Lance Baller | 2026-01-01 | Appointment to the Board of Directors. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | The Board of Directors approved the appointments of Mr. Kent Lund and Mr. Lance Baller as new members, increasing the board's size and expertise. | 2026-01-01 | Enhances the board's collective experience in legal, securities, finance, M&A, and corporate governance, likely improving oversight and strategic decision-making. |
Related Party Transactions
- Mr. Lance Baller previously served as CEO, Interim CEO, and Director of Selectis Health, Inc. from 2015 to 2023, indicating a prior relationship with the company before his current appointment to the Board.
Stakeholder Impact
- Shareholders: Likely positive impact due to strengthened corporate governance and strategic oversight from experienced directors, potentially leading to better long-term value creation.
- Management: Benefits from enhanced guidance and expertise from the board, particularly in legal, financial, and M&A strategies.
- Employees: No direct immediate impact mentioned, but improved corporate leadership can foster a more stable and strategically sound company environment.
- Customers/Suppliers: No direct immediate impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 2007 | Lance Baller served as CFO and Finance Director of Iofina Plc. |
| 2010 | Lance Baller served as CEO of Iofina Plc. |
| 2013 | Lance Baller concluded his role as CEO of Iofina Plc. |
| 2015 | Lance Baller began serving as CEO, Interim CEO, and Director of Selectis Health, Inc. |
| 2017 | Kent J. Lund began serving as a Member of the Colorado Securities Board. |
| 2018-11 | Kent J. Lund began serving as an Independent Member of the Board of Directors and audit committee member of JAB Wireless, Inc. |
| 2020-01 | Kent J. Lund began serving as a member of the FINRA West Region Committee. |
| 2020 | Kent J. Lund concluded his service on the Colorado Securities Board. |
| 2022-07 | Kent J. Lund concluded his service as an Independent Member of the Board of Directors and audit committee member of JAB Wireless, Inc. |
| 2023 | Lance Baller concluded his service as CEO, Interim CEO, and Director of Selectis Health, Inc. |
| 2025-12-31 | Kent J. Lund concluded his service as a member of the FINRA West Region Committee. |
| 2026-01-01 | Effective date of appointments of Mr. Kent Lund and Mr. Lance Baller to the Board of Directors of Selectis Health, Inc. |
| 2026-01-01 | Date of earliest event reported in the 8-K filing. |
| 2026-01-06 | Date the 8-K report was signed by Adam Desmond, CEO. |
Recommendation
buyThe appointment of two highly qualified and experienced directors, Kent J. Lund and Lance Baller, significantly strengthens Selectis Health's corporate governance and strategic capabilities. Mr. Lund brings critical legal, securities, and regulatory compliance expertise, while Mr. Baller, a former CEO of the company, offers deep operational, financial, and M&A acumen. This move enhances investor confidence by demonstrating a commitment to robust oversight and strategic leadership, making the stock a more attractive 'buy' for long-term investors seeking improved governance and potential for strategic growth.
Keywords
Selectis Health, Board of Directors, Corporate Governance, Kent J. Lund, Lance Baller, SEC Filing, 8-K, Director Appointment, Financial Reporting, Legal Compliance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.